Christian M. Vokuhl

Bonn, NW 53121, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 209 publications

Macroscopic venous tumour thrombus in paediatric adrenocortical tumours.

Macroscopic venous tumour thrombus in paediatric adrenocortical tumours.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 08, 2026

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Journal: International journal of molecular sciences
Published: April 17, 2026

Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT).

Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT).

Journal: Pediatric blood & cancer
Published: April 09, 2026

Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP-WT-2001 Protocol in the SIOP-UK-CCLG and SIOP-GPOH Studies (2001-2022).

Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP-WT-2001 Protocol in the SIOP-UK-CCLG and SIOP-GPOH Studies (2001-2022).

Journal: Pediatric blood & cancer
Published: March 29, 2026

Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study.

Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 13, 2026

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents.

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents.

Journal: Pediatric blood & cancer
Published: January 11, 2026

Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models.

Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models.

Journal: Cancer letters
Published: January 05, 2026

Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models.

Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models.

Journal: Cancer letters
Published: January 05, 2026

The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children's Hepatic tumors International Collaboration (CHIC).

The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children's Hepatic tumors International Collaboration (CHIC).

Journal: Cancer
Published: December 29, 2025

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor.

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor.

Journal: Pediatric blood & cancer
Published: December 23, 2025

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

Journal: The oncologist
Published: December 23, 2025

Spatial dissection of antibody-drug conjugate/radiopharmaceutical therapy targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors.

Spatial dissection of antibody-drug conjugate/radiopharmaceutical therapy targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors.

Journal: Neuro-oncology
Published: December 19, 2025
Showing 1-12 of 209

Last Updated: 09/26/2026